Video PlayerClose
A staff member holds packages of dexamethasone at a pharmacy in Manchester, Britain, on June 17, 2020. With the COVID-19 pandemic imposing huge impact on people's daily life in Britain and other parts of the world, scientists are racing against time to get deeper understanding of the novel coronavirus while accelerating the development of new treatments and vaccines. Through the British government backed RECOVERY (Randomized Evaluation of COVID-19 Therapy) trial, researchers have found that low-dose dexamethasone (a steroid treatment) reduces death in hospitalized patients with severe respiratory complications of COVID-19. (Photo by Jon Super/Xinhua)